|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02415 MEDSCI
Nominal 
0.780 +0.010 (+1.299%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 38,036 | (14,042) | 37,351 | 56,200 |
| Net Cash from / (used in) Investing Activities | -- | (494,974) | (2,133) | (2,034) | 31,414 |
| Net Cash from / (used in) Financing Activities | -- | 470,928 | (7,516) | 285,556 | 93,091 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 13,990 | (23,691) | 320,873 | 180,705 |
| Cash & Cash Equivalents at beginning of period | -- | 599,266 | 596,002 | 276,972 | 96,393 |
| Effect of Foreign Exchange Rate Changes | -- | 15,332 | 26,955 | (1,843) | (126) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 628,588 | 599,266 | 596,002 | 276,972 |
| Remarks: | Real time quote last updated: 15/11/2024 11:56 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 248,000 |
| %Change | -97.919% |
| EPS / (LPS) | RMB 0.001 |
| NBV Per Share (¥) | RMB 1.884 |